Correction to: Brigatinib in Japanese patients with tyrosine kinase inhibitor-naive ALK-positive non-small cell lung cancer: first results from the phase 2  J-ALTA study

Source: International Journal of Clinical Oncology - Category: Cancer & Oncology Source Type: research